Industry - Biotechnologies latest news

Precision Stability Storage, LLC (PSS) announced today that it is finalizing plans to open a new facility in New England. The expansion is expected to be made in a few stages over the next several months. (PRWEB May 8, 2008) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1aZXRhLVByb2YtRW1wdC1DcmFzLVplcm8=

Boehringer Ingelheim announces commitment to progressing science in this area of unmet medical need with the 'Bouquet' Studies - - May 2008 - For medical media, outside the US only - - Ingelheim/ Germany... [WebWire - Thursday, May 08, 2008]

CARDIFF, CA (MARKET WIRE) NI Research announces the publication of CNS 2008: Disorders/Therapeutics. The 2008 edition of this incomparable CNS industry overview incorporates a first-in-class evaluation of Big Pharma licensing skills and styles; Big Pharma Report Card: Business Development.

The pain patch on which BioDelivery Sciences International has bet its future came up a winner in its latest round of human testing, the Raleigh drug company said Thursday.

MONTREAL, QUEBEC (MARKET WIRE) Adaltis Inc. (TSX: ADS), an international in vitro diagnostic company, today held its annual meeting of shareholders at which it highlighted progress on its execution plan, specifically on the important steps forward taken to become a leading provider of immunoassay diagnostic systems in emerging markets, specifically focusing on China. Adaltis President and Chief Executive Officer, Pierre Larochelle, updated shareholders on the key decisions taken and implemented over the past year to accelerate the transition of Adaltis into a China-based company.

REDWOOD CITY, CA (MARKET WIRE) PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the quarter ended March 31, 2008. The results of the company's commercial and cardiovascular operations segment are presented as discontinued operations. The assets related to this segment were sold in March 2008. The financial results for continuing and discontinued operations are summarized below and are included, in addition to supplemental information, in the financial tables accompanying this press release.

PDL BioPharma, Inc. today reported financial results for the quarter ended March 31, 2008. The results of the company's commercial and cardiovascular operations segment are presented as discontinued operations. The assets related to this segment were sold in March 2008. The financial results for continuing and discontinued operations are summarized below and are included, in addition to supplemental information, in the financial tables accompanying this press release.

Medical device company NuVasive Inc. said Thursday it will buy Osiris Therapeutics Inc.'s Osteocol unit, which includes a developing bone graft stem cell treatment.

MEDFORD, NY (MARKET WIRE) Chembio Diagnostics, Inc. (OTCBB: CEMI), a developer and manufacturer of rapid diagnostic tests for infectious diseases, announced today that the company will release financial results for the first quarter ended March 31, 2008, following the close of the market on Monday, May 12, 2008.

Quintiles Transnational will add to its fast-growing consulting business after signing an agreement to purchase Boston-based Eidetics.